PDL BioPharma, Inc.

PDLI

Statistics

$2.79Share Price
$425 MMarket Cap
40.0%EBIT / EV
14.0%FCF / EV
25.9%ROIC
9.1%Cash ROIC
-9.1%3yr Avg Revenue Growth
1.94Current Ratio
star logo

Business Model Diligence

We do not yet have Business Model Diligence for this stock.

Statistical Diligence

check mark The EBIT / Enterprise Value of 40.0% ranks as Suspicious.
check mark The Free Cash Flow / Enterprise Value of 14.0% ranks as Very High.
check mark The Return on Invested Capital Value of 25.9% ranks as Very High.
check mark The Cash Return on Capital Value of 9.1% ranks as Average.
x mark The 3 Year Average Revenue Growth Value of -9.1% ranks as Poor.
check mark Near-term Financial Health appears to be Very Good. The Current Ratio is 1.94.

Company Description

PDL BioPharma, Inc. produces and markets biopharmaceutical products. It focuses on intellectual property asset management, investing in new royalty bearing assets and maximizing the value of its patent portfolio and related assets. The company manages a portfolio of patents and royalty assets, consisting of its Queen et al. patents, license agreements with various biotechnology and pharmaceutical companies, and royalty and other assets acquired. PDL BioPharma was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Incline Village, NV.

Calculations

You must have a MagicDiligence Membership to view the Calculations for this stock. If you are already a member, you need to log in first.
Tracking Portfolios
blue wand Magic Recipe 29.36%
purple wand Deep Value 24.71%
orange wand Quality Growth 44.22%
green wand Green Team 6.14%
red dot Red Rating 5.76%
yellow dot Yellow Rating 14.17%
green dot Green Rating 14.95%
New Spell Stocks
purple wand New Stocks Added!
orange wand New Stocks Added!